- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 27th, 2006
A small band of researchers scattered around the country from East Tennessee State University to Harvard's Brigham and Women's Hospital are about to test a new, nanotech approach to heading off a potential bird flu pandemic.
The scientists are developing liposomes, fatty globules used as a tiny drug delivery device, which contain a mix of antioxidants and anti-viral drugs. The researchers believe that these liposomes, which can be reduced to a size as small as 25 to 50 nanometers, can cripple the lethal chain reaction that allows a virus to replicate, saving the patient.
|Related News Press|
Research team led by NUS scientists develop plastic flexible magnetic memory device: Novel technique to implant high-performance magnetic memory chip on a flexible plastic surface without compromising performance July 21st, 2016
Graphene photodetectors: Thinking outside the 2-D box July 21st, 2016